Free Trial

Elekta (OTCMKTS:EKTAY) Shares Gap Up - What's Next?

Elekta logo with Medical background

Elekta AB (OTCMKTS:EKTAY - Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $5.00, but opened at $5.19. Elekta shares last traded at $5.14, with a volume of 1,106 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Danske downgraded shares of Elekta to a "hold" rating in a research note on Tuesday, June 3rd.

Get Our Latest Stock Analysis on EKTAY

Elekta Trading Up 0.4%

The stock's fifty day moving average price is $5.12 and its 200 day moving average price is $5.36. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.09 and a quick ratio of 0.86. The stock has a market capitalization of $1.99 billion, a P/E ratio of 103.82 and a beta of 1.20.

Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). The company had revenue of $503.22 million during the quarter, compared to the consensus estimate of $507.19 million. Elekta had a return on equity of 11.55% and a net margin of 1.15%. Research analysts forecast that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Featured Articles

Should You Invest $1,000 in Elekta Right Now?

Before you consider Elekta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta wasn't on the list.

While Elekta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines